Momenta Pharmaceuticals, Inc. Announces Date of Fourth Quarter and Year End 2012 Financial Results Conference Call and Webcast
CAMBRIDGE, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the fourth quarter ended December 31, 2012 before the U.S. financial markets open on Friday, February 15, 2013.